Astrotech Subsidiary 1ST Detect Announces Successful Pre-Clinical Trials for Mass Spectrometer Used as a Rapid Bedside Breathalyzer

By | Press Release

Astrotech (NASDAQ: ASTC) subsidiary 1st Detect, in collaboration with The University of Texas Health Science Center, now called UT Health San Antonio, announced positive preliminary results in pre-clinical trials for the BreathDetect 1000 – a rapid bedside breathalyzer for detecting bacterial infections in the respiratory tract, such as hospital-acquired pneumonia (HAP).

Read More

Astrotech Subsidiary 1ST Detect to Pursue Strategic Alternatives

By | Press Release

Astrotech Corporation’s (NASDAQ: ASTC) board of directors and management announce that they have engaged Chardan to advise on strategic alternatives involving Astrotech subsidiary 1ST Detect Corporation, a manufacturer of advanced mass spectrometry technology used to detect and analyze trace levels of explosives, chemical warfare agents (CWAs), and volatile organic compounds (VOCs).

Read More